---
schema_version: "secwatch.filing_event.v1"
accession: "0001835268-25-000061"
form_type: "8-K"
ticker: "CNTB"
cik: "0001835268"
company_name: "Connect Biopharma Holdings Ltd"
filed_at: "2025-12-23T23:59:59+00:00"
generated_at: "2026-05-16T12:17:29.096852+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Connect Biopharma board member Kan Chen resigns amid U.S.-centric shift

## Summary
- Kan Chen, Ph.D., partner at Qiming Venture Partners, resigned from Board and Nominating Committee effective Dec 17, 2025.
- Resignation not due to any disagreement with company on operations, policies or practices.
- Chen cited company's successful strategic shift to become more U.S.-centric as appropriate time to step down.

## SEC filing metadata
- accession: 0001835268-25-000061
- form_type: 8-K
- ticker: CNTB
- cik: 0001835268
- company_name: Connect Biopharma Holdings Ltd
- filed_at: 2025-12-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/0001835268-25-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000061/cntb-20251217.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001835268-25-000061
- JSON: https://secwatch.observer/filing/0001835268-25-000061.json
- Plain text: https://secwatch.observer/filing/0001835268-25-000061.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.